methylone (TSND-201)
/ Otsuka
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 24, 2026
EMPOWER-2: An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
(clinicaltrials.gov)
- P3 | N=300 | Recruiting | Sponsor: Transcend Therapeutics
New P3 trial • CNS Disorders • Mood Disorders • Post-traumatic Stress Disorder
1 to 1
Of
1
Go to page
1